Latest Period
Q2 2026
Security Snapshot
Pulmonx Corp - Common Stock (LUNG) Institutional Ownership
CUSIP: 745848101
13F Institutional Holders and Ownership History from Q4 2020 to Q2 2026
Institutions Reporting
60
Shares (Excl. Options)
10,381,322
Price
$1.30
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock
- Symbol
- LUNG on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 10,381,322
- Total 13F value
- $13,498,632
- Portfolio coverage rank
- 0%
- Share change
- -4,903,135
- Value change
- -$6,379,103
- Number of holders
- 60
- Shares outstanding
- 42,322,333
- SEC-reported price per share
- $1.47
- Insider filing price
- $1.47
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- LUNG - Pulmonx Corp - Common Stock is tracked under CUSIP 745848101.
- 60 institutions reported positions in Q2 2026.
- 5 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 111 to 60 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $40,902,623 to $13,498,632.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 60 institutions filings for Q2 2026.
Security key
745848101
Latest holder period
Q2 2026
13F holders
60
13D/G owners
5
CIK / CUSIP context first
Open Q2 2026 holders
LUNG full holder history
Pulmonx Corp SEC filings
Pulmonx Corp company facts
Pulmonx Corp insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 745848101:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
5
Security
LUNG
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| PRIMECAP MANAGEMENT CO/CA/ | 12% | -10% | $8,029,839 | -$742,073 | 4,956,691 | -8.5% | PRIMECAP MANAGEMENT CO/CA/ | 30 Sep 2025 |
| MORGAN STANLEY | 6.9% | -18% | $4,292,754 | -$691,629 | 2,920,241 | -14% | Morgan Stanley | 30 Jun 2026 |
| Soleus Capital Master Fund, L.P. | 6.5% | $4,344,113 | 2,665,100 | Soleus Capital Master Fund, L.P. | 06 Mar 2026 | |||
| BlackRock, Inc. | 1.8% | -71% | $995,514 | -$2,508,253 | 765,721 | -72% | BlackRock, Inc. | 30 Jun 2026 |
| FMR LLC | 0.2% | -104% | $114,736 | -$3,416,852 | 70,825 | -97% | FMR LLC | 31 Oct 2025 |
As of 30 Jun 2026, 60 institutional investors reported holding 10,381,322 shares of Pulmonx Corp - Common Stock (LUNG). This represents 25% of the company’s total 42,322,333 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
24%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| MORGAN STANLEY | 6.9% | 2,922,921 | -27% | 0% | $3,799,797 |
| Soleus Capital Management, L.P. | 6.6% | 2,788,323 | 0% | 0.12% | $3,624,820 |
| BlackRock, Inc. | 2.1% | 882,490 | -67% | 0% | $1,147,238 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.1% | 452,684 | -52% | 0% | $588,714 |
| RENAISSANCE TECHNOLOGIES LLC | 1% | 425,110 | +33% | 0% | $552,643 |
| DEUTSCHE BANK AG\ | 0.95% | 402,316 | -65% | 0% | $523,011 |
| CFM WEALTH PARTNERS LLC | 0.62% | 264,039 | 0% | 0.04% | $343,251 |
| VANGUARD FIDUCIARY TRUST CO | 0.59% | 250,511 | -11% | 0% | $325,664 |
| MARSHALL WACE, LLP | 0.55% | 230,738 | 0% | $299,959 | |
| ACADIAN ASSET MANAGEMENT LLC | 0.53% | 223,141 | +34% | 0% | $287,000 |
| STATE STREET CORP | 0.45% | 191,501 | -76% | 0% | $248,951 |
| GSA CAPITAL PARTNERS LLP | 0.32% | 136,157 | -0.97% | 0.01% | $177,000 |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 0.26% | 110,000 | 0% | 0% | $143,000 |
| BANK OF MONTREAL /CAN/ | 0.25% | 105,958 | 0% | $137,745 | |
| NORTHERN TRUST CORP | 0.25% | 104,119 | -71% | 0% | $135,355 |
| Redhawk Wealth Advisors, Inc. | 0.24% | 99,648 | +187% | 0.01% | $129,542 |
| ALGERT GLOBAL LLC | 0.23% | 98,332 | +15% | 0% | $127,832 |
| DIMENSIONAL FUND ADVISORS LP | 0.23% | 97,791 | -31% | 0% | $127,243 |
| IEQ CAPITAL, LLC | 0.16% | 69,158 | +220% | 0% | $89,906 |
| Quadrature Capital Ltd | 0.15% | 63,910 | 0% | $83,083 | |
| MERCER GLOBAL ADVISORS INC /ADV | 0.14% | 61,332 | +26% | 0% | $79,732 |
| Berger Financial Group, Inc | 0.13% | 54,000 | 0% | 0% | $70,200 |
| BRIGHTON JONES LLC | 0.13% | 53,231 | +19% | 0% | $69,201 |
| FJARDE AP-FONDEN /FOURTH SWEDISH NATIONAL PENSION FUND | 0.09% | 40,000 | 0% | 0% | $52,000 |
| PERKINS CAPITAL MANAGEMENT INC | 0.09% | 39,500 | -3.7% | 0.04% | $51,350 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
23
Latest
Q2 2026
Rows shown
1-23 of 23
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 10,381,322 | $13,498,632 | -$6,379,103 | $1.30 | 60 |
| 2026 Q1 | 31,742,669 | $40,902,623 | -$1,886,778 | $1.29 | 111 |
| 2025 Q4 | 32,396,800 | $71,586,474 | +$3,228,827 | $2.21 | 113 |
| 2025 Q3 | 31,835,122 | $51,571,453 | -$11,678,469 | $1.62 | 104 |
| 2025 Q2 | 36,256,022 | $93,898,311 | -$4,596,833 | $2.59 | 113 |
| 2025 Q1 | 36,156,132 | $243,324,576 | +$1,663,003 | $6.73 | 114 |
| 2024 Q4 | 35,870,967 | $243,565,337 | +$1,640,704 | $6.79 | 117 |
| 2024 Q3 | 35,563,337 | $293,811,542 | +$7,857,689 | $8.29 | 112 |
| 2024 Q2 | 34,744,517 | $220,280,080 | -$2,027,570 | $6.34 | 108 |
| 2024 Q1 | 34,672,382 | $321,430,455 | +$7,599,744 | $9.27 | 117 |
| 2023 Q4 | 33,520,168 | $427,381,569 | +$18,995,295 | $12.75 | 122 |
| 2023 Q3 | 33,253,122 | $343,505,198 | -$6,689,600 | $10.33 | 113 |
| 2023 Q2 | 33,869,172 | $443,992,925 | -$9,642,079 | $13.11 | 112 |
| 2023 Q1 | 34,707,575 | $388,032,205 | +$25,513,692 | $11.18 | 101 |
| 2022 Q4 | 33,773,100 | $284,706,913 | -$83,075,336 | $8.43 | 111 |
| 2022 Q3 | 34,912,391 | $581,637,070 | -$4,909,166 | $16.66 | 100 |
| 2022 Q2 | 35,341,147 | $520,187,047 | -$7,902,826 | $14.72 | 102 |
| 2022 Q1 | 34,711,340 | $861,059,885 | +$56,937,629 | $24.81 | 105 |
| 2021 Q4 | 32,045,807 | $1,027,712,027 | +$25,949,573 | $32.07 | 108 |
| 2021 Q3 | 31,600,475 | $1,136,986,158 | +$204,291,164 | $35.98 | 118 |
| 2021 Q2 | 25,771,799 | $1,136,970,052 | +$216,275,676 | $44.12 | 112 |
| 2021 Q1 | 20,788,776 | $950,879,909 | +$115,760,357 | $45.74 | 107 |
| 2020 Q4 | 17,288,638 | $1,179,671,046 | +$1,018,686,046 | $69.02 | 98 |